Buscar
Mostrando ítems 1-10 de 174
The pharmacological treatment of obesity: A historical perspective
(Academia Nacional de Medicina venezolana., 2022)
Tratamiento farmacológico o quirúrgico del paciente con sobrepeso u obesidad
(Sociedad Médica de Santiago, 2009)
Statement about the medical and surgical treatment of overweight and obesity Tratamiento farmacológico o quirúrgico del paciente con sobrepeso u obesidad
(2009)
This is an updated review of the available treatments for obesity, that can be used when lifestyles modifications fail. Using the available information and the experience of the members of this advisory group, a recommendation ...
Encapsulated peptides and proteins with an effect on fatiety
(Nanomaterials, 2023)
Encapsulated peptides and proteins with an effect on satiety
(Nanomaterials, 2023)
Oxintomodulina e obesidade
(Pontifícia Universidade Católica de Campinas, 2009-10-01)
Since the discovery of leptin, great advances occurred in the characterization of hypothalamic mechanisms involved in the control of food intake and oxyntomodulin is currently recognized as a homeostasis energy regulator. ...
Insights into the Molecular Requirements for the Anti-obesity Activity of a Series of CB1 Ligands
(WILEY-BLACKWELL, 2010)
Two-dimensional and 3D quantitative structure-activity relationships studies were performed on a series of diarylpyridines that acts as cannabinoid receptor ligands by means of hologram quantitative structure-activity ...
Can sibutramine alter systemic blood pressure in obese patients? Systematic review and meta-analysis
(Associação Paulista de Medicina - APM, 2008-11-01)
CONTEXT: Systemic arterial hypertension is part of the metabolic syndrome resulting from obesity. OBJECTIVE: To evaluate the effect of sibutramine on overweight and obese patients' blood pressure through a systematic review. ...